Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor study

Blood

Volumn 110, Issue 10, 2007, Pages 3784-3792

  Bhatia, Smita ^a   Francisco, Liton ^a   Carter, Andrea ^a   Sun, Can Lan ^a   Scott Baker, K ^b   Gurney, James G ^c   McGlave, Philip B ^b   Nademanee, Auayporn ^a   O'Donnell, Margaret ^a   Ramsay, Norma K C ^b   Robison, Leslie L ^d   Snyder, David ^a   Stein, Anthony ^a   Forman, Stephen J ^a   Weisdorf, Daniel J ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE;

EID: 36348990261     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-03-082933     Document Type: Article

References (25)

1. Horowitz MM. Uses and growth of hematopoietic cell transplantation. In: Blume KG, Forman S, Appelbaum ER, eds. Thomas' Hematopoietic Cell Transplantation. Malden, MA: Blackwell Publishing; 2004:9-15.
2. Gluckman E, Socie G, Claisse JP, Hirsch I. Long term results of allogeneic bone marrow transplantation. Bone Marrow Transplant. 1993;12(suppl 4):S13-S15.
3. Socie G, Veum-Stone J, Wingard JR, et al. Long term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med. 1999;341:14-21.
4. Duell T, van Lint MT, Ljungman P, et al. Health and functional status of long-term survivors of bone marrow transplantation: EBMT Working Party on Late Effects and EULEP Study Group on Late Effects, European Group for Blood and Marrow Transplantation. Ann Intern Med. 1997;126:184-192.
5. Andrykowski M, Henslee PJ, Farrall MG. Physical and psychological functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant. 1989;4:75-81.
6. Andrykowski M, Henslee PJ, Barnett RL. The quality of life in adult survivors of allogeneic bone marrow transplantation: correlates and comparison with matched renal transplant recipients. Transplantation. 1990;50:399-406.
7. Wingard JR, Curbow B, Baker F, Piantadosi S. Health, functional status, and employment of adult survivors of bone marrow transplantation. Ann Int Med. 1991;114:113-118.
8. Marsh G, Ehland J, Sefcik S, Youk A. Mortality and Population Data System. Pittsburgh, PA: University of Pittsburgh; 2000.
9. Breslow N, Day N. Statistical methods in cancer research: IARC Workshop 25-27 May 1983. IARC Sci Publ. 1987;82:1-406.
10. Vandenbroucke JP. A shortcut method for calculating the 95 percent confidence interval of the standard mortality ratio. Am J Epidemiol. 1982;115:303-304.
11. Cox DR. Regression models and life tables. J R Stat Soc. 1972;834:187-220.
12. Curb JD, Ford CE, Pressel S, et al. Ascertainment of vital status through the National Death Index and the Social Security Administration. Am J Epidemiol. 1985;121:754-766.
13. Deeg HJ, Leisenring W, Storb R, et al. Long-term outcome after marrow transplantation for severed aplastic anemia. Blood. 1998;91:3637-3645.
14. Witherspoon RP, Fisher LD, Schnoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med. 1989;321:784-789.
15. Socie G, Curtis RE, Deeg HJ, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol. 2000;18:348-357.
16. Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors after treatment of aplastic anemia: European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993;329:1152-1157.
17. Bhatia S, Ramsay K, Steinbuch M, et al. Malignant neoplasms following bone marrow transplantation. Blood. 1996;87:3633-3639.
18. Krishnan A, Bhatia S, Slovak ML, et al. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood. 2000;95:1588-1593.
19. Metayer C, Curtis RE, Vose JM. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multcenter casecontrol study. Blood. 2003;101:2015-2023.
20. Bhatia S, Louie A, Bhatia R, et al. Solid cancers after bone marrow transplantation. J Clin Oncol. 2001;19:464-471.
21. Flowers MED, Deeg HJ. Delayed complications after hematopoietic cell transplantation. In: Blume KG, Forman S, Appelbaum ER, eds. Thomas' Hematopoietic Cell Transplantation. Malden, MA: Blackwell Publishing; 2004:944-961.
22. Kreisman H, Kolkove N. Pulmonary toxicity of antineoplastic therapy. Semin Oncol. 1992;19:508-520.
23. Holme GE, Baker A, Hassanein RS, et al. The availability of insurance to long-term survivors of childhood cancer. Cancer. 1986;57:190-193.
24. Green DM, Zevon MA, Hall B. Achievement of life goals by adult survivors of modern treatment for childhood cancer. Cancer. 1991;67:206-213.
25. Hays DM, Landsverk J, Sallan SE, et al. Educational, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life. J Clin Oncol. 1992;10:1397-1406.